Cite
The Preventive Antibiotics in Stroke Study (PASS): a pragmatic randomised open-label masked endpoint clinical trial.
MLA
Westendorp, Willeke F., et al. “The Preventive Antibiotics in Stroke Study (PASS): A Pragmatic Randomised Open-Label Masked Endpoint Clinical Trial.” Lancet (London, England), vol. 385, no. 9977, Apr. 2015, pp. 1519–26. EBSCOhost, https://doi.org/10.1016/S0140-6736(14)62456-9.
APA
Westendorp, W. F., Vermeij, J.-D., Zock, E., Hooijenga, I. J., Kruyt, N. D., Bosboom, H. J. L. W., Kwa, V. I. H., Weisfelt, M., Remmers, M. J. M., ten Houten, R., Schreuder, A. H. C. M. T., Vermeer, S. E., van Dijk, E. J., Dippel, D. W. J., Dijkgraaf, M. G. W., Spanjaard, L., Vermeulen, M., van der Poll, T., Prins, J. M., … Nederkoorn, P. J. (2015). The Preventive Antibiotics in Stroke Study (PASS): a pragmatic randomised open-label masked endpoint clinical trial. Lancet (London, England), 385(9977), 1519–1526. https://doi.org/10.1016/S0140-6736(14)62456-9
Chicago
Westendorp, Willeke F, Jan-Dirk Vermeij, Elles Zock, Imke J Hooijenga, Nyika D Kruyt, Hans J L W Bosboom, Vincent I H Kwa, et al. 2015. “The Preventive Antibiotics in Stroke Study (PASS): A Pragmatic Randomised Open-Label Masked Endpoint Clinical Trial.” Lancet (London, England) 385 (9977): 1519–26. doi:10.1016/S0140-6736(14)62456-9.